Göran Landberg
CHAIR
MOLECULAR PATHOLOGY
University of Manchester
United Kingdom
Biography
Professor Göran Landberg holds a medical degree from Umeå University, Sweden. After medical school he presented a PhD in pathology at Umeå University detailing cell cycle alterations in cancer. He then moved to The Scripps Research Institute in San Diego to work on cell cycle related auto antigens as a postdoctoral fellow. On returning to Sweden, he started his own research group at Umeå University and finished his histopathology training. In 2000, he moved to Lund University as a professor in Pathology with affiliation to Malmö University Hospital (UMAS). In 2008, he was appointed as professor in Molecular Pathology at Manchester University and the first Team Leader at the Breakthrough Breast Cancer Research Unit in Manchester. He is the founder of the Swedish Tissue Micro Array Centre and member of the executive committee of the Swedish Cancer Foundation. He has produced more than 100 peer-reviewed articles and several patents related to novel targets in breast cancer therapy.Professor Göran Landberg holds a medical degree from Umeå University, Sweden. After medical school he presented a PhD in pathology at Umeå University detailing cell cycle alterations in cancer. He then moved to The Scripps Research Institute in San Diego to work on cell cycle related auto antigens as a postdoctoral fellow. On returning to Sweden, he started his own research group at Umeå University and finished his histopathology training. In 2000, he moved to Lund University as a professor in Pathology with affiliation to Malmö University Hospital (UMAS). In 2008, he was appointed as professor in Molecular Pathology at Manchester University and the first Team Leader at the Breakthrough Breast Cancer Research Unit in Manchester. He is the founder of the Swedish Tissue Micro Array Centre and member of the executive committee of the Swedish Cancer Foundation. He has produced more than 100 peer-reviewed articles and several patents related to novel targets in breast cancer therapy.
Research Interest
MOLECULAR PATHOLOGY
